Arhaus (ARHS) Will Announce Earnings Tomorrow: What You Should Know
Arhaus Earnings Preview: What to Watch
This Thursday morning, luxury furniture retailer Arhaus (NASDAQ:ARHS) is set to announce its latest earnings. Here’s a breakdown of what investors should keep an eye on.
In the previous quarter, Arhaus outperformed revenue forecasts, posting $344.6 million—a year-over-year increase of 8%. The company also exceeded EBITDA projections, though its guidance for the upcoming quarter fell short of analyst expectations.
Revenue Forecasts and Market Sentiment
For this quarter, analysts anticipate Arhaus’s revenue will rise by 1% compared to last year, reflecting a relatively stable performance.
Over the past month, most analysts have maintained their estimates, indicating expectations for steady results. However, Arhaus has missed Wall Street’s revenue targets several times in the last two years.
Industry Peers: Recent Results
Other companies in the home furnishings and improvement retail sector have already released their fourth-quarter numbers, offering some context:
- Floor And Decor reported a 2% increase in revenue, matching analyst predictions, and saw its stock rise 4.3% after the announcement.
- Home Depot experienced a 3.8% drop in revenue, which was in line with consensus estimates.
2025 Outlook and Market Trends
The forecast for 2025 is uncertain, with possible changes in trade policies and corporate taxes potentially affecting business sentiment and growth. Although some home improvement retailers have performed well despite market volatility, the sector as a whole has lagged, with average share prices falling 2.4% over the past month. Arhaus shares have dropped 18.4% in the same period, and analysts currently set their price target at $11.35, compared to the present price of $8.41.
Spotlight on Thematic Investing
At StockStory, we recognize the value of investing in major trends. Companies like Microsoft, Alphabet, Coca-Cola, and Monster Beverage have all been standout growth stories driven by powerful themes.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Sector agroexportador de Perú bajo amenaza tras alertas de intensas lluvias por "El Niño costero"
3 Key Factors Driving the Strong Performance of Mining ETFs
Sanofi’s Wayrilz Receives Orphan Drug Designation for IgG4-Related Disease in Japan
Sanofi's Wayrilz Receives Orphan Drug Designation for IgG4-Related Disease in Japan
